Welcome to our dedicated page for Globe Life SEC filings (Ticker: GL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Globe Life Inc. filings document operating results, governance and capital-structure disclosures for an insurance holding company focused on life and supplemental health insurance. Current reports include earnings releases furnished on Form 8-K, with disclosures on net income, net operating income, underwriting margins, premium revenue and guidance.
Proxy and governance filings cover director elections, shareholder voting results, advisory executive compensation matters, board composition, non-employee director compensation and executive retirement plan amendments. The filing record also identifies registered securities including common stock and subordinated debt, alongside recurring disclosures tied to shareholder meetings and corporate governance procedures.
Globe Life Inc filed a Form 144 notice reporting the sale of 2,000 shares of Common Stock in a stock option exercise on 06/18/2026. The filing also lists prior sales by Rebecca E. Zorn of 8,800 shares on 03/31/2026 for $1,202,189.45.
GLOBE LIFE INC. executive Dolores L. Skarjune reported option exercises combined with open-market sales of company stock. On 2026-06-12, she exercised employee stock options covering 1,700 shares at a strike price of $103.23 per share and 2,475 shares at $98.32 per share, converting derivative awards into common stock. She then sold 874 shares at $167.2530 per share, 1,103 shares at $166.5095 per share, and 2,198 shares at $165.5846 per share in open-market transactions. Following these transactions, she directly holds 15,673.734 shares of common stock and indirectly holds 2,894.735 shares through a 401(k) plan, while the option positions referenced in this filing have been fully exercised.
Globe Life Inc. executive Robert Brian Mitchell, EVP, General Counsel and CRO, reported a bona fide gift of 1,250 shares of Globe Life common stock by the Mitchell Family Trust. After this gift, that trust holds 43,369.3294 shares, while Mitchell also reports additional indirect and direct holdings in Globe Life stock.
GLOBE LIFE INC. Co-Chairman & CEO Frank M. Svoboda reported a two-day exercise-and-sell pattern in common stock. On June 11–12, 2026, he exercised employee stock options to acquire a total of 20,000 shares of common stock at an exercise price of $100.74 per share.
Over the same period, he executed open-market sales totaling 20,000 shares at weighted-average prices around the mid‑$160s per share, with individual trades occurring in ranges from $163.935 to $167.425 per share, as disclosed in footnotes. After these transactions, he directly held 54,020.4648 shares of common stock.
The filing also reports indirect holdings as of June 11, 2026, including 1,955.294 shares in a 401(k) plan, 26,425 shares in a spouse’s irrevocable trust, 5,000 shares in an irrevocable trust, and 103,473 shares in a family trust.
Globe Life Inc. reported a proposed sale of 25,000 shares resulting from a stock option exercise dated 06/11/2026. The filing also discloses two recent dispositions: 12,854 shares on 05/05/2026 for $1,974,421.95 and 20,000 shares on 05/22/2026 for $3,133,588.00.
The transaction lists Apex Clearing as the broker-dealer and shows a shares outstanding figure of 77,126,827 as of 06/11/2026.
GLOBE LIFE INC. executive Robert Brian Mitchell, EVP, General Counsel and Chief Risk Officer, reported recent transactions in the company’s common stock. Through the Mitchell Family Trust, there were open-market sales totaling 600 shares at prices around $155.56 per share, along with a bona fide gift of 320 shares.
After these movements, the Mitchell Family Trust held 44,619.3294 shares. Additional indirect holdings were reported as 12,649.982 shares in a 401(k) plan and 1,861.049 shares in a son’s trust, and direct holdings were 7,980.8271 shares as of the latest reported date.
GLOBE LIFE INC. executive vice president and CFO Thomas Peter Kalmbach reported a combination of option exercise and share sale involving the company’s common stock. He exercised employee stock options for 10,000 shares at an exercise price of $103.23 per share and converted them into common stock.
On the same date, he sold 7,936 common shares in an open-market transaction at an average price of $156.5914 per share, with actual sale prices ranging from $156.25 to $157.08 per share. Following these transactions, he holds 50,495.7065 common shares directly and 1,152.787 shares indirectly through a 401(k) plan.